Am. J. Respir. Crit. Care Med., Volume 165, Number 3, February 2002, 378-381

Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases

HIROSHI OHNISHI, AKIHITO YOKOYAMA, KEIICHI KONDO, HIRONOBU HAMADA, MASAHIRO ABE, KAZUTAKA NISHIMURA, KUNIO HIWADA, and NOBUOKI KOHNO

Second Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan; Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima, Japan; and the Department of Respiratory Medicine, Ehime National Hospital, Ehime, Japan

KL-6, surfactant protein (SP)-A, SP-D, and monocyte chemoattractant protein-1 (MCP-1) are reported to be sensitive markers for interstitial lung diseases (ILD). However, each marker has been studied independently. The aim of this study was a comparative analysis of the diagnostic values of these markers. Subjects consisted of 33 patients with ILD (21 cases of idiopathic pulmonary fibrosis and 12 associated with collagen vascular diseases) and 82 control subjects (12 cases of bacterial pneumonia and 70 healthy volunteers). Receiver operating characteristic curves revealed that KL-6 was superior to the other markers. The cut-off levels for these markers that resulted in the highest diagnostic accuracy were determined to be 465 U/ml for KL-6, 48.2 ng/ml for SP-A, 116 ng/ml for SP-D, and 1080 pg/ml for MCP-1. The sensitivity, specificity, and diagnostic accuracy were 93.9%, 96.3%, and 95.7% for KL-6; 81.8%, 86.6%, and 85.2% for SP-A; 69.7%, 95.1%, and 87.8% for SP-D; and 51.5%, 92.7%, and 80.9% for MCP-1; respectively. The serum levels of SP-A and SP-D, but not of KL-6, were significantly higher in patients with bacterial pneumonia than in healthy volunteers. These results suggest that of the markers studied, KL-6 is the best serum marker for ILD.

This article has been cited by other articles:

				R. M. Determann, E. K. Wolthuis, G. Choi, P. Bresser, A. Bernard, R. Lutter, and M. J. Schultz Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L344 - L350. [Abstract] [Full Text] [PDF]

				T Hamaguchi, K Omae, T Takebayashi, Y Kikuchi, N Yoshioka, Y Nishiwaki, A Tanaka, M Hirata, O Taguchi, and T Chonan Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage Occup. Environ. Med., January 1, 2008; 65(1): 51 - 55. [Abstract] [Full Text] [PDF]

				E. Miyazaki, S.-i. Nureki, E. Ono, M. Ando, O. Matsuno, T. Fukami, T. Ueno, and T. Kumamoto Circulating Thymus- and Activation-Regulated Chemokine/CCL17 Is a Useful Biomarker for Discriminating Acute Eosinophilic Pneumonia From Other Causes of Acute Lung Injury Chest, June 1, 2007; 131(6): 1726 - 1734. [Abstract] [Full Text] [PDF]

				T. Chonan, O. Taguchi, and K. Omae Interstitial pulmonary disorders in indium-processing workers Eur. Respir. J., February 1, 2007; 29(2): 317 - 324. [Abstract] [Full Text] [PDF]

				C. P. McSharry, I. Fraser, R. Chaudhuri, K. Anderson, S. J. Bourke, N. C. Thomson, and G. Boyd Nerve growth factor in serum and lymphocyte culture in pigeon fanciers' acute hypersensitivity pneumonitis. Chest, July 1, 2006; 130(1): 37 - 42. [Abstract] [Full Text] [PDF]

				R. Janssen, A. Kruit, J. C. Grutters, H. J. Ruven, W. B. Gerritsen, and J. M. van den Bosch The Mucin-1 568 Adenosine to Guanine Polymorphism Influences Serum Krebs von den Lungen-6 levels Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 496 - 499. [Abstract] [Full Text] [PDF]

				H Tsukamoto, K Nagafuji, T Horiuchi, T Miyamoto, K Aoki, K Takase, H Henzan, D Himeji, T Koyama, K Miyake, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease Ann Rheum Dis, April 1, 2006; 65(4): 508 - 514. [Abstract] [Full Text] [PDF]

				Q. A. Al-Salmi, J. N. Walter, G. N. Colasurdo, M. M. Sockrider, E. O. Smith, H. Takahashi, and L. L. Fan Serum KL-6 and Surfactant Proteins A and D in Pediatric Interstitial Lung Disease Chest, January 1, 2005; 127(1): 403 - 407. [Abstract] [Full Text] [PDF]

				H. Sato, M.E.J. Callister, S. Mumby, G.J. Quinlan, K.I. Welsh, R.M. duBois, and T.W. Evans KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome Eur. Respir. J., January 1, 2004; 23(1): 142 - 145. [Abstract] [Full Text] [PDF]

				R. Janssen, H. Sato, J. C. Grutters, A. Bernard, H. van Velzen-Blad, R. M. du Bois, and J. M. M. van den Bosch Study of Clara Cell 16, KL-6, and Surfactant Protein-D in Serum as Disease Markers in Pulmonary Sarcoidosis Chest, December 1, 2003; 124(6): 2119 - 2125. [Abstract] [Full Text] [PDF]

				H Ohnishi, A Yokoyama, Y Yasuhara, A Watanabe, T Naka, H Hamada, M Abe, K Nishimura, J Higaki, J Ikezoe, et al. Circulating KL-6 levels in patients with drug induced pneumonitis Thorax, October 1, 2003; 58(10): 872 - 875. [Abstract] [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355. [Full Text] [PDF]

				M. N. Gong and E. J. Mark Case 40-2002 - A 56-Year-Old Man with Rapidly Worsening Dyspnea N. Engl. J. Med., December 26, 2002; 347(26): 2149 - 2157. [Full Text] [PDF]